DnB Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378K | Buy |
11,455
+1,021
| +10% | +$33.7K | ﹤0.01% | 662 |
|
|
2025
Q1 | $419K | Buy |
10,434
+1,221
| +13% | +$49.1K | ﹤0.01% | 668 |
|
|
2024
Q4 | $433K | Buy |
9,213
+1,826
| +25% | +$85.9K | ﹤0.01% | 670 |
|
|
2024
Q3 | $390K | Buy |
7,387
+156
| +2% | +$8.24K | ﹤0.01% | 668 |
|
|
2024
Q2 | $392K | Buy |
7,231
+645
| +10% | +$34.9K | ﹤0.01% | 663 |
|
|
2024
Q1 | $462K | Buy |
+6,586
| New | +$462K | ﹤0.01% | 657 |
|